Breast Cancer Clinical Trials

Showing 3241-3260 of 5,597 trials

Analyzing the Composition of Tears to Identify Cancer

NCT00574678

This study will further evaluate the use of protein identification or protein pattern (signature) found in tears. We hypothesize that differences exist between the protein profile in tear fluid from patients with versus without cancer.

Breast CancerOvarian CancerColon Cancer+1 more

University of Arkansas150 participantsStarted Dec 2006

Little Rock, Arkansas, United States

COMPLETED

The Role of Magnetic Resonance Imaging in Assessment of Axillary Lymph Nodes Metastasis in Breast Cancer Patients.

NCT03163316

Breast cancer is the most common cancer among women worldwide.The main cause of cancer related death is the invasion and metastasis. The usual site of spread outside the breast is to lymph nodes in the axilla.

Breast Cancer Female

Assiut University30 participantsStarted Dec 2017

Asyut, Egypt • Asyut, Egypt

COMPLETED

Treatment After Palbociclib-containing Regimens

NCT04517318

To evaluate the prescription patterns and treatment outcomes of subsequent therapies after progression on palbociclib in the real world.

Breast Cancer

Fudan University200 participantsStarted Aug 2017

Shanghai, Shanghai Municipality, China

Analyzing the Composition of Tears to Identify Cancer

The Role of Magnetic Resonance Imaging in Assessment of Axillary Lymph Nodes Metastasis in Breast Cancer Patients.

Treatment After Palbociclib-containing Regimens

Related Searches

Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases

The Validation of Sentinel Lymph Node Biopsy After Neo-adjuvant Chemotherapy in Breast Cancer Patients

ciNPT in Autologous Abdominal Tissue Breast Reconstruction

Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Triple-Negative MBC and Tesetaxel Monotherapy in Patients With HER2-Negative MBC

Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC

AFT: Introduction of a Full Breast Reconstructive Method

PalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer

Development of Artificial Intelligence System for Detection and Diagnosis of Breast Lesion Using Mammography

Neo-RT: A Study Investigating Whether Changing the Sequence of Treatments (Starting Radiotherapy Followed by Hormone Therapy Before Surgery) is Feasible

E-monitoring of Patients Under Adjuvant Hormonotherapy for Breast Cancer.

Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health

RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast Cancer

Trastuzumab Combined With Pertuzumab for Adjuvant Treatment of Breast Cancer After Neoadjuvant Therapy

Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer

Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer

Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer

Breast Mesh Used in Two-staged Breast Reconstruction